Heart Disease, Congenital Clinical Trial
Official title:
Review of Outcomes Following Pulmonary Valve Replacement for Congenital Heart Disease in Adults
One of the most common residual lesions in adult survivors of pediatric cardiac surgery is
pulmonary valve disease, particularly regurgitation.
Multiple studies have demonstrated that placement of a pulmonary valve in such patients,
results in improved ventricular function and resolution of symptoms. However, the optimal
prosthetic valve for use in the pulmonary position has not been defined. There are
essentially three alternatives available: the stented bioprosthetic valve, stentless
bioprosthetic "tube" grafts used to replace the entire right ventricular outflow tract and
mechanical valves.
All three of these valve options have been used in adults with congenital heart disease at
Emory Healthcare and at Children's Healthcare of Atlanta at Egleston.
The goal of this study is to evaluate and compare the indications and short and mid-term
outcomes for these alternative therapies.
n/a
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00308217 -
Single Ventricle Outcome
|
N/A |